Intervet patent opposition analysis

The comprehensive analysis of Intervet opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Intervet

Patent NumberTitleApplicantOpposition DateOpposition Company
Virus-Like Particle (Vlp)PHARMAQ ASNov 19, 2025INTERVET
Vaccine Composition Against Streptococcus Suis InfectionCEVA SANTÉ ANIMALE S.A.Jul 27, 2021INTERVET
Pestivirus Vaccines For Congenital TremorsIOWA STATE UNIVERSITY RESEARCH FOUNDATIONOct 28, 2020INTERVET
Vectors For Transforming Mycoplasma Hyopneumoniae, Transformed M. Hyopneumoniae Strains, And Use ThereofHIPRA SCIENTIFICMar 26, 2020INTERVET
Recombinant Gallid Herpesvirus 3 (Mdv Serotype 2) Vectors Expressing Antigens Of Avian Pathogens And Uses ThereofMERIALSep 30, 2019INTERVET
Porcine Parvovirus 5A, Methods Of Use And VaccineHRINGApr 23, 2019INTERVET
Immunogenic Compositions Comprising Lawsonia IntercellularisHRINGApr 2, 2019INTERVET
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such CompositionsHRINGOct 23, 2018INTERVET
Method Of Providing Protective Immunity Against Heterologous Leptospira StrainsHRINGSep 26, 2018INTERVET
Treatment Of Pigs With Pcv2 AntigenBOEHRINGER INGELHEIMNov 22, 2017INTERVET

Top companies who are the clients of Intervet

CompanyTotal
INTERVET15